Performance of population pharmacokinetic models in predicting polymyxin b exposures
10.3390/microorganisms8111814
Saved in:
Main Authors: | Tam, V.H., Lee, L.S., Ng, T.-M., Lim, T.-P., Cherng, B.P.Z., Adewusi, H., Hee, K.H., Ding, Y., Chung, S.J., Ling, L.-M., Chlebicki, P., Kwa, A.L.H., Lye, D.C. |
---|---|
其他作者: | MEDICINE |
格式: | Article |
出版: |
MDPI AG
2021
|
主題: | |
在線閱讀: | https://scholarbank.nus.edu.sg/handle/10635/199406 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
機構: | National University of Singapore |
相似書籍
-
Clinical experience with high-dose polymyxin b against carbapenem-resistant gram-negative bacterial infections—a cohort study
由: Cai, Y., et al.
出版: (2021) -
Susceptibility Testing for the Polymyxins: Two Steps Back, Three Steps Forward?
由: Vasoo, Shawn
出版: (2018) -
Optimizing hollow-fiber-based pharmacokinetic assay via chemical stability study to account for inaccurate simulated drug clearance of rifampicin
由: New, L.S., et al.
出版: (2014) -
Weighted area under the receiver operating characteristic curve and its application to gene selection
由: Li, J., et al.
出版: (2014) -
In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against Carbapenem-resistant Acinetobacter baumannii in Singapore
由: Lim T.-P., et al.
出版: (2019)